Chicago Capital
RVMD icon

Chicago Capital’s Revolution Medicines RVMD Stock Holding History

Chicago Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$56.4M Buy
274,561
+22,714
+9% +$4.5M 1.3% 25
2026
Q2 		$47.2M Buy
+251,847
New +$36.8M 1.14% 29

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak
Loftus Peak Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Chicago Capital's RVMD Position: Q3 2026 in Review

Chicago Capital increased its Revolution Medicines (RVMD) stake by 9% in Q3 2026, buying an estimated $4.5M and bringing the position to 274,561 shares worth $56.4M. The position accounts for 1.3% of the portfolio, ranked #25.

Chicago Capital first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 219 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Chicago Capital held 274,561 shares of Revolution Medicines worth $56.4M as of Q3 2026.
  • Chicago Capital bought 22,714 Revolution Medicines shares in Q3 2026, an estimated $4.5M.
  • Revolution Medicines made up 1.3% of Chicago Capital's portfolio in Q3 2026, its #25 holding.
  • Chicago Capital first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 219 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Chicago Capital's 13F filing for Q3 2026, filed 13 Oct 2026.